Dentists' attitudes, behaviors, and barriers related to tobacco‐use cessation in the dental setting
…, S Silverstein, R Meckstroth, B Heckman… - Journal of public …, 2013 - Wiley Online Library
Objective: This study assessed attitudes, behaviors, and barriers among general dentists in
California, Pennsylvania, and West Virginia, related to patient tobacco cessation counseling. …
California, Pennsylvania, and West Virginia, related to patient tobacco cessation counseling. …
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
…, DH Watts, P Jean-Philippe, B Heckman… - Antimicrobial agents …, 2011 - Am Soc Microbiol
Tenofovir (TFV) is effective in preventing simian immunodeficiency virus (SIV) transmission
in a macaque model, is available as the oral agent tenofovir disoproxil fumarate (TDF), and …
in a macaque model, is available as the oral agent tenofovir disoproxil fumarate (TDF), and …
Oral health prevention and toddler well-child care: routine integration in a safety net system
METHODS: Over 3 years, the team developed clinical policies, educational materials, billing,
and support systems to facilitate implementation in the primary care setting. A pilot study …
and support systems to facilitate implementation in the primary care setting. A pilot study …
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy
…, R Hazra, L Serchuck, BE Heckman… - The Pediatric …, 2009 - journals.lww.com
Background: With increasing recognition of the benefits of early antiretroviral therapy initiation
in perinatally HIV-infected infants, data are needed regarding the pharmacokinetics (PK), …
in perinatally HIV-infected infants, data are needed regarding the pharmacokinetics (PK), …
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human …
…, SA Spector, MD Decker, BE Heckman… - The Pediatric …, 2010 - journals.lww.com
Background: Quadrivalent meningococcal polysaccharide conjugate vaccine (MCV4) is
routinely recommended for healthy youth in the United States, but there are no data about its …
routinely recommended for healthy youth in the United States, but there are no data about its …
[HTML][HTML] Randomized controlled trial of a remote coaching mHealth adherence intervention in youth living with HIV
…, A Dunlap, R Goolsby, MM Johnson, B Heckman… - AIDS and Behavior, 2022 - Springer
Youth living with HIV (YLWH) in the US have low rates of viral suppression (VS). In a prospective
randomized clinical trial (ATN152) that enrolled 89 YLWH on antiretroviral therapy (ART…
randomized clinical trial (ATN152) that enrolled 89 YLWH on antiretroviral therapy (ART…
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT …
…, K Calabrese, K Baltrusaitis, B Heckman… - The Lancet …, 2024 - thelancet.com
Background Long-acting injectable cabotegravir and rilpivirine have demonstrated safety,
acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA study…
acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA study…
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV …
…, SR Mathiba, A Adeyeye, JH Moye, B Heckman… - The Lancet …, 2024 - thelancet.com
Background Combined intramuscular long-acting cabotegravir and long-acting rilpivirine
constitute the first long-acting combination antiretroviral therapy (ART) regimen approved for …
constitute the first long-acting combination antiretroviral therapy (ART) regimen approved for …
Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women
…, DH Watts, T Fenton, B Heckman… - Clinical infectious …, 2013 - academic.oup.com
Background. Pregnant women infected with human immunodeficiency virus (HIV) may have
particular vulnerability to 2009 pandemic H1N1 influenza (pH1N1) infection. The safety and …
particular vulnerability to 2009 pandemic H1N1 influenza (pH1N1) infection. The safety and …
[HTML][HTML] Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
…, M Tomu, L Fairlie, K George, B Heckman… - BMC infectious …, 2022 - Springer
Background Tenofovir disoproxil fumarate (TDF) in combination with other antiretroviral (ARV)
drugs has been in clinical use for HIV treatment since its approval in 2001. Although the …
drugs has been in clinical use for HIV treatment since its approval in 2001. Although the …